Global private equity and venture capital news and research

Posts Tagged ‘biotech’

13 October 2016

Biotech PE, VC investment falls back to earth after stellar August $

dna-163466_1280 Private equity and venture capital investment in biotech businesses crashed back to earth following a new 12-month high in August, new research shows.

19 September 2016

Biotech balloons for second August running thanks to single mega-deal $

hot-air-balloon-244794_1920 A single mammoth deal in the biotech sector helped the sector's private equity investment figures through the roof in August, new research shows.

22 August 2016

Biotech scores biggest monthly PE, VC total deal value of year to date

fractal-1280072_1920 Private equity and venture capital dealmaking in the biotech sector hit its biggest monthly value of the year to date in July, largely thanks to a single $400m deal.

18 July 2016

May biotech PE, VC deal numbers boom falls back to earth $

dna-694798_1920 The number of biotech deals done by private equity and venture capital firms has dropped back sharply from May's 12-month high, new research shows.

9 June 2016

Biotech continues month-on-month rise in PE, VC investment $

research-1029340_1920 The value of private equity, venture capital and development capital targeting biotech companies increased for the third successive month in May to $498m, new research shows.

31 May 2016

5AM Ventures raises $285m for biggest-ever fund

sunrise-182302_1280 Biotech-focused 5AM Ventures has raised at least $285m for its fifth fund, less than three years after closing its formerly largest-ever fundraise on $250m.

25 May 2016

Albion sells biotech business Haemostatix

blood-75302_1280 Albion Ventures and other investors have sold their stakes in biotech business Haemostatix.

13 April 2016

Month-on-month uptick still leaves biotech PE, VC investment at relative low $

research-1029340_1920 Private equity and venture capital investment in biotech companies received a slight uptick in March, but still recorded one of its leanest results in the past 12 months, new research shows.

10 March 2016

PE, VC biotech investment hits new 12-month low $

flasks-606612_1920 Private equity and venture capital investment in the biotech sector hit a new 12-month low last month amid consecutives falls in both volume and total value.

23 October 2015

Israel Biotech targets $100m for debut fund

isr Newly formed venture capital firm Israel Biotech Fund has launched its first fund with a $100m target, AltAssets understands.

Page 1 of 1412345...10...Last »

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016